The efficacy of nonoxynol-9 from an in vivo point of view.
Wittkowski
K M
KM
D005260:Female; D006069:Gonorrhea / Q000517:prevention & control; D015658:HIV Infections / Q000517:prevention & control / Q000635:transmission; D006558:Herpes Genitalis / Q000517:prevention & control; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D017137:Nonoxynol / Q000009:adverse effects / Q000627:therapeutic use*; D012749:Sexually Transmitted Diseases / Q000517:prevention & control*; D013089:Spermatocidal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014247:Trichomonas Vaginitis / Q000517:prevention & control
D013089:Spermatocidal Agents; D017137:Nonoxynol